To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.

2/7/2025, 5:54 PM

Summary of Bill HR 1060

Bill 119 HR 1060 aims to update the Federal Food, Drug, and Cosmetic Act in order to improve the way controlled substances are authenticated in the pharmaceutical distribution supply chain. The bill seeks to modernize the methods used to verify the authenticity of these substances, with the goal of enhancing safety and security within the supply chain.

The proposed legislation includes provisions that would require the use of advanced technologies, such as blockchain and other digital authentication methods, to track and verify the movement of controlled substances throughout the distribution process. By implementing these technologies, the bill aims to reduce the risk of counterfeit or fraudulent drugs entering the supply chain, ultimately protecting consumers from potentially harmful substances.

In addition to enhancing authentication methods, the bill also includes measures to improve communication and collaboration among stakeholders in the pharmaceutical industry. This includes requirements for increased transparency and information sharing between manufacturers, distributors, and regulators, in order to better monitor and control the distribution of controlled substances. Overall, Bill 119 HR 1060 seeks to modernize and strengthen the authentication processes for controlled substances in the pharmaceutical supply chain, with the ultimate goal of improving safety and security for consumers.

Congressional Summary of HR 1060

Modern Authentication of Pharmaceuticals Act of 2025

This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.

The bill applies to products manufactured beginning five years after the bill's enactment.

Current Status of Bill HR 1060

Bill HR 1060 is currently in the status of Bill Introduced since February 6, 2025. Bill HR 1060 was introduced during Congress 119 and was introduced to the House on February 6, 2025. Bill HR 1060's most recent activity was Referred to the House Committee on Energy and Commerce. as of February 6, 2025

Bipartisan Support of Bill HR 1060

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 1060

Primary Policy Focus

Alternate Title(s) of Bill HR 1060

To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.